Semaglutide 5 mg

DRAGON PHARMA SEMAGLUTIDE

Semaglutide is a medication used in the management of type 2 diabetes. It belongs to the class of glucagon-like peptide-1 (GLP-1) receptor agonists.

DRUG COMPOSITION

Semaglutide is composed of synthetic analogs designed to mimic the action of naturally occurring GLP-1.

LAB TEST REPORT

PHARMACEUTICAL FORM

It is commonly available in freeze-dried powder, injectable form, either as a solution for subcutaneous injection or as a pre-filled pen.

PHARMACEUTICAL GROUP AND ATC CODE

Pharmaceutical group: Antidiabetic agents. ATC code: A10BJ06.

PHARMACOLOGICAL PROPERTIES

Semaglutide stimulates insulin release, inhibits glucagon secretion, and slows gastric emptying, contributing to improved blood glucose control.

PROFILE

• Chemical name: Semaglutide
• Chemical formula: C187H291N45O59
• Percentage of anabolic activity: Not applicable (not an anabolic steroid)
• Percentage of androgenic activity: Not applicable
• Active half life: Approximately 1 week
• Recommended dosage: Varies, typically once weekly
• Acne: Not a known side effect
• Bloating (water retention): Not a known side effect
• HBR: Not applicable
• Hepatic toxicity: Not a known side effect
• Aromatization: Not applicable

THERAPEUTICAL INDICATIONS

Semaglutide is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

DOSES AND METHOD OF ADMINISTRATION

The typical dose is administered subcutaneously once a week. The injection site may vary.

CYCLE/STACKING

Semaglutide is generally used continuously for the management of type 2 diabetes, and cycles are not applicable.

POST CYCLE THERAPY

Post cycle therapy is not relevant in the context of semaglutide use for diabetes management.

SIDE EFFECTS

Common side effects may include nausea, vomiting, diarrhea, and abdominal pain. Serious side effects are rare but may include pancreatitis and thyroid tumors.

CONTRAINDICATIONS

Semaglutide is contraindicated in patients with a history of hypersensitivity to the drug and in those with a personal or family history of medullary thyroid carcinoma.

OVERDOSE

Overdose may result in hypoglycemia. Treatment involves glucose administration.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

Caution is advised in patients with a history of pancreatitis, and regular monitoring for signs of thyroid tumors is recommended.

INTERACTIONS WITH OTHER DRUGS

Interactions may occur with other antidiabetic medications, and close monitoring is necessary when used in combination.

PRESENTATION, PACKAGING

2 mL vial.

STORAGE

Semaglutide should be stored according to the manufacturer's instructions, usually refrigerated, after reconstitution from powder.

DELIVERY TO THE USA

Semaglutide is available for secure and discreet delivery to the USA through authorized supplier - Steroid.biz.

LEGAL STATUS

Prescription medication; its legal status may vary by country.

LAB TEST RESULTS

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Dragon Pharma
Europe

EXTERNAL LINKS

• Semaglutide Wiki, wikipedia.org
• Semaglutide: uses, dosage, side effects, brands, drugs.com
• Semaglutide Injection: MedlinePlus Drug Information, medlineplus.gov.